Home › Compare › CLSZF vs ABBV
CLSZF yields 15873.02% · ABBV yields 3.06%● Live data
📍 CLSZF pulled ahead of the other in Year 1
Combined, CLSZF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLSZF + ABBV for your $10,000?
China Oil And Gas Group Limited, an investment holding company, primarily invests in natural gas and energy related businesses in the People's Republic of China and Canada. The company operates through four segments: Sales and Distribution of Natural Gas and Other Related Products; Gas Pipeline Construction and Connection; Exploitation and Production of Crude Oil and Natural Gas; and Production and Sales of Coal Gasification and Other Related Products. It is involved in the piped city gas business, as well as design and construction of gas pipelines; and the transportation, distribution, and sale of compressed natural gas and liquefied natural gas. The company also develops, produces, and sells crude oil and natural gas, and other upstream energy resources; constructs and operates gas pipelines and natural gas stations; and provision for finance, as well as involved in the trading of natural gas and related equipment. In addition, it operates natural gas stations for automobiles. The company serves approximately 1,765,241 residential users; and 15,602 industrial and commercial users. China Oil And Gas Group Limited is headquartered in Causeway Bay, Hong Kong.
Full CLSZF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.